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Available online 12 August 2016The postnatal mammalian heart is considered a terminally differentiated organ unable to efﬁciently regenerate
after injury. In contrast, we have recently shown a remarkable regenerative capacity of the prenatal heart
using myocardial tissue mosaicism for mitochondrial dysfunction in mice. This model is based on inactivation
of the X-linked gene encoding holocytochrome c synthase (Hccs) speciﬁcally in the developing heart. Loss of
HCCS activity results in respiratory chain dysfunction, disturbed cardiomyocyte differentiation and reduced
cell cycle activity. The Hccs gene is subjected to X chromosome inactivation, such that in females heterozygous
for the heart conditionalHccs knockout approximately 50% of cardiac cells keep the defective X chromosome ac-
tive and develop mitochondrial dysfunction while the other 50% remain healthy. During heart development the
contribution of HCCS deﬁcient cells to the cardiac tissue decreases from 50% atmid-gestation to 10% at birth. This
regeneration of the prenatal heart is mediated by increased proliferation of the healthy cardiac cell population,
which compensates for the defective cells allowing the formation of a fully functional heart by birth. Herewe per-
formedmicroarray RNA expression analyses on 13.5 dpc control and heterozygousHccs knockout hearts to iden-
tifymolecular mechanisms that drive embryonic heart regeneration. Array data have been deposited in the Gene
Expression Omnibus (GEO) database under accession number GSE72054.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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array typeAffymetrix GeneChip Mouse Genome 430 2.0 arraysata format Raw and processed
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factorsHeterozygous heart conditional Hccs (Holocytochrome c
synthase) knockout (cHccs+/−) versus littermate control
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featuresTotal RNA was isolated from whole 13.5 dpc embryonic hearts
and processed for hybridization to Affymetrix arrays. 5
biological replicates per genotype (i.e. cHccs+/− versus
controls) each containing 4–5 pooled hearts were analyzed.onsent Not applicable
mple source
locationMünster, Germany1. Direct link to deposited data
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE72054D. Drenckhahn).
. This is an open access article under2. Experimental design, materials and methods
2.1. Experimental design
The prenatal mammalian heart has a remarkable regenerative ca-
pacity and can compensate for the presence of diseased cells or cardio-
myocyte loss to build fully functional hearts by birth [1,2]. In order to
identify molecular mechanisms that drive embryonic heart regenera-
tion, we utilized a genetic mouse model based on inactivation of the
X-linked gene encoding holocytochrome c synthase (Hccs) in the devel-
oping heart [1]. Heterozygous heart conditional Hccs knockout female
embryos (cHccs+/−) develop a tissue mosaic of mitochondrial dysfunc-
tion at 10.5 dpc, such that the myocardium is composed of 50% healthy
and diseased cardiomyocytes, respectively. During heart development
the contribution of HCCS deﬁcient cells to the cardiac tissue decreases
from 50% at mid-gestation to 10% at birth. This regeneration of the pre-
natal heart is mediated by increased proliferation of the healthy cardiac
cell population, allowing the formation of a fully functional heart at
birth. Nevertheless, HCCS deﬁcient cardiomyocytes do not undergo
cell death but survive embryonic and fetal development and are still de-
tectable in the postnatal heart. Here we performed microarray RNA ex-
pression analyses on 13.5 dpc control and cHccs+/− hearts. At this
developmental stage the most dramatic changes in tissue composition
occur in cHccs+/− ventricular myocardium, as hyperproliferation ofthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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substantial contribution of HCCS deﬁcient cells is still present (Fig. 1).
This should allow the identiﬁcation of genes involved in compensatory
growth of healthy cells as well as survival of defective cells.
2.2. Mice
The generation and characterization of heart conditionalHccsknock-
out (KO) mice has been described previously [1]. Brieﬂy, “ﬂoxed” (ﬂ)
Hccs mice were bred to mice expressing Cre recombinase under the
control of the Nkx2.5 promoter. All mice were maintained on a mixed
129Sv/C57Bl6 genetic background and all embryo experiments were
performed on heterozygous Hccs KO females (Hccsﬂ/+/Nkx2.5Cre, re-
ferred to as cHccs+/−) and their respective Cre positive female litter-
mate controls (Hccs+/+/Nkx2.5Cre, referred to as Hccs+/+).
2.3. Preparation of embryonic hearts
For embryo generation females were mated to the respective males
and checked for vaginal plug the next morning. The day of an observed
plug was deﬁned as 0.5 dpc and embryos were prepared at 13.5 dpc.
Dams were sacriﬁced by cervical dislocation and embryos were quickly
dissected from the uterus into cold PBS.Whole hearts (including ventri-
cles, atria and parts of the outﬂow tract)were removed from the thorac-
ic cavity, rinsed in cold PBS to wash out blood and snap frozen in liquid
nitrogen. Tail tissue was used for DNA preparation and PCR genotyping
[1].
2.4. RNA isolation
Given the small size of 13.5 dpc mouse hearts, to purify sufﬁcient
RNA amounts suitable for microarray analyses an average of 4 to 5
hearts of the same genotype were pooled. This procedure furthermore
accounts for interindividual aswell as environmental ormaternal differ-
ences during pregnancy. RNA was puriﬁed using the RNeasy Mini Kit
(Qiagen). The tissue was homogenized in RLT buffer supplemented
with β-mercaptoethanol using a micropestle. Total RNA was isolatedFig. 1. Regeneration of the embryonic heart in cHccs+/− female mice. The prenatal
cHccs+/− heart is composed of healthy (depicted in red) and diseased (i.e. HCCS
deﬁcient) cardiomyocytes harboring a defect in the mitochondrial respiratory chain
(depicted in green). At mid-gestation (i.e. 10.5 dpc) a 50:50 ratio of healthy versus
diseased cells is observed in the myocardium, whereas the contribution of diseased
tissue progressively declines to just 10% prior to birth. This embryonic heart
regeneration is mediated by increased proliferation of healthy cardiomyocytes, which
compensate for the defective cells to build a fully functional heart by birth. Nevertheless,
HCCS deﬁcient cells survive fetal development and are still detectable in the postnatal
heart. Transcriptional proﬁling of regenerating cHccs+/− hearts has been performed at
13.5 dpc.via spin columns according to themanufacturer's instructions, including
digestion of genomic DNA on the column using the RNase-Free DNase
Set (Qiagen). RNA purity and quality was tested using spectrophoto-
metric parameters and a Bioanalyzer (Agilent), respectively. All samples
used for subsequent microarray analyses had RNA integrity numbers
(RIN) of ≥8.8.
2.5. Microarray RNA expression analyses
For microarray expression analyses a total of 10 Affymetrix
GeneChip Mouse Genome 430 2.0 arrays were used. Five pooled sam-
ples per genotype (i.e. cHccs+/− and control female embryos) were an-
alyzed. cDNA synthesis was performed using Live Technologies
SuperScript® One-Cycle cDNA Kit followed by in vitro transcription
using the MEGAScript T7 Kit. After fragmenting of the cRNA for target
preparation using the standard Affymetrix protocol, 15 μg fragmented
cRNA was hybridized for 16 h at 45 °C to the Mouse Genome 430
array. Arrayswerewashed and stainedwith streptavidin-phycoerythrin
in the Affymetrix Fluidics Station 450 following standard procedures
and further scanned using the Affymetrix GeneChip Scanner 3000 7G.
2.6. Data processing and analysis
Arrays have beenquantile-normalize using the RMAalgorithm. RMA
normalization was performed using Partek Genomic Suite version 6.3,
RMA background correction, quantile normalization and median polish
probeset summarization. Not or low expressed transcripts were re-
moved by a (log2)maximum expression cutoff b 6. The data ﬁltering re-
sulted in 18,571 of 45,101 probe sets. After normalization the arrays
were checked for outlier using the principal component analysis
(PCA), a correlation dispersionmatrix and normalized Eigenvector scal-
ing. No outlier has been detected. Differential expression was
ascertained using t-statistic followed by a FDR multiple testing correc-
tion [3]. Probes which undergo 5% FDR were further investigated by
functional enrichment using g:Proﬁler [4], with a simulation based ana-
lytical threshold for signiﬁcance estimation.
3. Discussion
The microarray RNA expression analyses described above revealed
437 genes differentially expressed in 13.5 dpc cHccs+/− compared to
control hearts, the majority of which are involved in protein and
amino acid metabolism, unfolded protein response (UPR), translational
control, cellular stress response and cell death regulation (for details see
(5)). Most of the genes and pathways regulating cell stress, UPR and ap-
optosis could be assigned to HCCS deﬁcient cardiomyocytes, which like-
ly contributes to their survival within the myocardium [5]. In contrast,
the transcriptional signature of the healthy cardiomyocyte population
is less clear. In this regard it is important to note that we used whole
13.5 dpc cHccs+/− hearts containing a tissue mosaic of healthy and
HCCS deﬁcient cardiomyocytes for microarray analyses. Subtle changes
in one of the two cell populations are easily missed if not sufﬁcient to
alter expression levels in RNA samples isolated from whole hearts. Al-
though the cellular response to mitochondrial dysfunction in the dis-
eased cardiomyocyte population is the dominating outcome of our
analyses, the microarray data is likely to also contain genes speciﬁcally
regulated in the healthy cardiomyocyte population. Identiﬁcation of
the latter would be most relevant for cardiomyocyte cell cycle regula-
tion and cardiac regeneration. Consequently, we do not claim to provide
a full list of differentially expressed genes in the regenerating cHccs+/−
heart [5], but future studies using laser microdissection or ﬂuorescence
activated cell sorting (FACS) will be required to separate the two cell
populations. This would allow to more thoroughly deﬁne gene expres-
sion changes speciﬁc for healthy and HCCS deﬁcient cardiomyocytes,
respectively.
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